COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,761 Articles (22,502 medRxiv, 8,259 bioRxiv)

Most recent first Previous |  Page 1447: Articles 14461-14470  | Next

Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals
Planas, D., Veyer, D., Baidaliuk, A., Staropoli, I., Guivel-Benhassine, F., Rajah, M., Planchais, C., Porrot, F., Robillard, N., Puech, J., Prot, M., Gallais, F., Gantner, P., Velay, A., Le Guen, J., Kassis-Chikhani, N., Edriss, D., Belec, L., Seve, A., Pere, H., Courtellemenont, L., Hocqueloux, L., Fafi-Kremer, S., Prazuck, T., Mouquet, H., Bruel, T., Simon-Loriere, E., Rey, F., Schwartz, O.
10.1101/2021.05.26.445838 — Posted: 2021-05-27
SARS-CoV-2 inactivation by human defensin HNP1 and retrocyclin RC-101
Kudryashova, E., Zani, A., Vilmen, G., Sharma, A., Lu, W., Yount, J. S., Kudryashov, D. S.
10.1101/2021.05.27.445985 — Posted: 2021-05-27
A new method to study genome mutations using the information entropy
Vopson, M. M., Robson, S. C.
10.1101/2021.05.27.445958 — Posted: 2021-05-27
Development and performance of a population-based risk stratification model for COVID-19
Vela, E., Carot-Sans, G., Cleries, M., Monterde, D., Acebes, X., Comella, A., Garcia Eroles, L., Coca, M., Valero-Bover, D., Piera-Jimenez, J., Perez Sust, P.
10.1101/2021.05.25.21257783 — Posted: 2021-05-27
Early transfusion of convalescent plasma improves the clinical outcome in severe SARS-CoV2 infection
Fodor, E., Muller, V., Ivanyi, Z., Berki, T., Kuten, O. P., Ambrus, M., Sarkany, A., Skazel, A., Madar, A., Kardos, D., Kemenesi, G., Foldes, F., Nagy, S., Matusovits, A., Nacsa, J., Tordai, A., Jakab, F., Lacza, Z.
10.1101/2021.05.25.21257770 — Posted: 2021-05-27
PROMIS scales for assessment of the impact of post-COVID syndrome: A Cross-Sectional Study
Ganesh, R., Ghosh, A. K., Nyman, M. A., Croghan, I. T., Grach, S. L., Anstine, C. V., Hurt, R. T.
10.1101/2021.05.25.21257817 — Posted: 2021-05-27
Experimental investigation to verify if excessive plastic sheeting shielding produce micro clusters of SARS-CoV-2
Ishigaki, Y., Kawauchi, Y., Yokogawa, S., Saito, A., Kitamura, H., Moritake, T.
10.1101/2021.05.22.21257321 — Posted: 2021-05-27
Markers of brain and endothelial Injury and inflammation are acutely and sex specifically regulated in SARS-CoV-2 infection
Savarraj, J. P., Park, E. S., Copo, G., Hinds, S., Morales, D., Ahnstedt, H., Assing, A., Juneja, S., Kim, E., Cho, S.-M., Gusdon, A., Dash, P., McCullough, L., Choi, A.
10.1101/2021.05.25.21257353 — Posted: 2021-05-27
Recovery from the COVID-19 pandemic by mass vaccination: emergent lessons from the United States and India
Michael, E., Newcomb, K., Mubayi, A., Mahmood, I.
10.1101/2021.05.26.21257847 — Posted: 2021-05-27
Covid-19 and Mental Health of Individuals with Different Personalities
Proto, E., Zhang, A.
10.1101/2021.05.24.21257581 — Posted: 2021-05-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).